MyPEEPS Mobile Plus for HIV Prevention
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that you cannot participate if you are currently using PrEP consistently.
What data supports the effectiveness of the MyPEEPS Mobile Plus treatment for HIV prevention?
The MyPEEPS Mobile intervention has been adapted from an evidence-based, face-to-face HIV prevention program into a mobile app, showing promise in reducing sexual risk behaviors among young men. It has been designed to be user-friendly and effective in delivering HIV prevention information, particularly for young men who are at higher risk of HIV.12345
Is MyPEEPS Mobile Plus safe for humans?
How is the MyPEEPS Mobile treatment unique for HIV prevention?
MyPEEPS Mobile is unique because it is a mobile app designed to deliver HIV prevention and sexual health education specifically for young men, particularly those from diverse racial and ethnic backgrounds. Unlike traditional face-to-face interventions, it provides a portable, accessible platform that empowers users with information and strategies to reduce HIV risk behaviors.13456
What is the purpose of this trial?
MyPEEPS Mobile Plus, a multi-level intervention for improving HIV prevention outcomes in YMSM, is a novel and evidence-driven approach using mobile technology to deliver HIV prevention information specifically developed for YMSM. Building on strong preliminary work, the proposed research is the next logical step in a body of work designed to assess whether refinement of this mobile intervention used in combination with virtual PrEP Peer Navigation will result in improvements in PrEP uptake and a reduction in HIV-related behavior. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.
Research Team
Robert Garofalo, MD, MPH
Principal Investigator
Ann & Robert H Lurie Children's Hospital of Chicago
Lisa Kuhns, PhD, MPH
Principal Investigator
Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility Criteria
This trial is for young men who have sex with men (YMSM), considered at high risk for HIV. Participants should be interested in using mobile technology and virtual peer support to help prevent HIV infection.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention arm will have access to the MyPEEPS mobile application and Electronic peer PrEP navigation
Control
Participants in the control arm will receive standard of care information and access to the MyPEEPS Mobile App
Follow-up
Participants are monitored for PrEP initiation, adherence, and persistence, and HIV risk behavior
Treatment Details
Interventions
- Electronic PrEP peer navigation
- MyPEEPS Mobile
MyPEEPS Mobile is already approved in United States for the following indications:
- HIV prevention in young men who have sex with men (YMSM)
- HIV prevention in young transgender men and transmasculine youth
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Callen-Lorde Community Health Center
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator